We have compared the novel ( multiple monoamine neurotransmitter reuptake inhibitor ) antiobesity drug sibutramine ( 10 mg once daily ) with the extensively studied serotonin-releasing antiobesity agent dexfenfluramine ( 15 mg twice daily ) .
